KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Novavax (NVAX) Return on Capital Employed (2016 - 2025)

Novavax has reported Return on Capital Employed over the past 15 years, most recently at 0.63% for Q4 2025.

  • Quarterly results put Return on Capital Employed at 0.63% for Q4 2025, up 115.0% from a year ago — trailing twelve months through Dec 2025 was 0.63% (up 115.0% YoY), and the annual figure for FY2025 was 0.5%, up 97.0%.
  • Return on Capital Employed for Q4 2025 was 0.63% at Novavax, up from 0.37% in the prior quarter.
  • Over the last five years, Return on Capital Employed for NVAX hit a ceiling of 64.22% in Q1 2023 and a floor of 35.67% in Q2 2023.
  • Median Return on Capital Employed over the past 5 years was 0.68% (2024), compared with a mean of 0.16%.
  • Biggest five-year swings in Return on Capital Employed: soared 6707bps in 2023 and later tumbled -6474bps in 2024.
  • Novavax's Return on Capital Employed stood at 9.32% in 2021, then skyrocketed by 135bps to 3.27% in 2022, then plummeted by -288bps to 6.15% in 2023, then soared by 92bps to 0.52% in 2024, then soared by 222bps to 0.63% in 2025.
  • The last three reported values for Return on Capital Employed were 0.63% (Q4 2025), 0.37% (Q3 2025), and 0.38% (Q2 2025) per Business Quant data.